| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |